The weakness of pharmaceutical stocks continued beyond the weekend,
In particular, on the weekend, Medytox announced that it had signed a three-way negotiation with Abbey and Ebolus related to botulinum toxin, and went directly to the upper limit, but the pharmaceutical index collapsed at 12,000.
On the 22nd, the stock market drug index fell to 18,677.77, 296.16p (-1.56%) compared to the previous day, and the KOSDAQ market pharmaceutical index fell 170.97p (-1.41%) to 11,925.34.
Despite the bearish market, Medytox of the pharmaceutical index recorded an upper limit with the news that it reached an agreement through a three-party negotiation with Abbey and Ebolus as a result of an ITC lawsuit related to botulinum toxin.
In addition, shares of Korea Pharmaceutical (+8.26%), Humedix (+5.57%), NG Chem Life Science (+5.38%), and Futurechem (+5.16%) also rose more than 5%.
On the other hand, the share price of ISU Abgis (-12.29%) plunged more than 10%, and Seegene (-9.20%), Humasis (-7.61%), Kolon Life Science (-7.53%), Abclone (-5.19%), etc. The stock price also fell by more than 5%.
In the pharmaceutical index, Daewoong Pharmaceutical (+14.43%) recorded a double-digit increase rate, while Pamicel (+5.43%) and Shinpoong Pharmaceutical (+5.32%) rose 5%, and no stocks fell more than 5%.
Copyright © Medical News Unauthorized reproduction and redistribution prohibited